Anika Therapeutics, Inc. has released its financial results for the third quarter ending September 30, 2024, on October 31, 2024. The complete press release has been included as Exhibit 99.1. The information is furnished and is not intended to be deemed "filed" for regulatory purposes or incorporated by reference into any other filings.
Proper Names Mentioned: - Anika Therapeutics, Inc. - Cheryl R. Blanchard (President and Chief Executive Officer)